• 8:30 - 18:00 M-T / 8.30 - 15.00 F

Histocell took part in the 9th Congress of the Spanish Wound Society

Print

The ninth edition of the SEHER Congress was held in Madrid from March 27 to 29, with the aim of gathering all professionals dedicated to the management of different types of wounds.

Once again, we had the opportunity to continue making Reoxcare product known among those who still do not know it, as well as exchanging opinions with current customers.

Continue Reading

DEIA - Cosmética vasca, el "boom" de belleza

Print

Completamente alejada de la poción de un druida o de elixires mágicos, en una planta de Larrabetzu se elabora alta cosmética científica y tecnológica made in Euskadi.

Leer noticia completa

Histocell y Microdan alcanzan un acuerdo para reforzar la comercialización de Reoxcare en España

Print

Histocell, empresa biofarmacéutica de medicina regenerativa y Microdan, empresa especializada en seguridad del paciente, control de infección y tratamiento de heridas en hospitales, han sellado un acuerdo para colaborar en la comercialización de Reoxcare en España.

Continue Reading

Histocell will manufacture Enoc Pharma products at its new factory at Larrabetzu, Bizkaia

Print

Histocell has established a collaboration agreement with the Catalan firm Enoc Pharma, which will combine the technologies of both companies to develop and manufacture highly innovative medical devices and cosmetic products in Bizkaia. Under this agreement, Histocell will open a new product manufacturing line at its factory based on Advanced Liposome technology developed by Enoc Pharma. This is an important milestone for Histocell that realises how its commitment to manufacturing is backed within a few months of launching its production facility.

Continue Reading

Reoxcare was very well received at the SGH Congress

Print

The 13th and 14th of September was held in Vigo (Galicia, Spain) the IV Congreso SGH (Galician Wound Society), and Histocell took part in this event, participating as an exhibitor, and holding a symposium within the scientific program.

The SGH Congress is held bianually and aims to bring together all the health professionals united by their interest in applying excellent care to patients suffering from deterioration of skin and/or tissue integrity.

Continue Reading

Reoxcare present at the 29th Conference of the European Wound Management Association, EWMA 2019

Print

From the 5th to the 7th of June, the 29th Conference of the European Wound Management Association took place in Gothenburg and gathered the European and international wound management communities with the common goal of improving the care of wound patients.

Histocell took part as exhibitor, as well as in the scientific programme with the presentation of the poster “Control of oxidative stress to activate non-healing wounds: case series”. The poster describes 34 non-healing wounds from different etiologies treated with Reoxcare, where Reoxcare effectively contributed to overcome the inflammatory phase, induced granulation tissue formation and the activation of wound edges.

Continue Reading

Histocell Headquarters

Parque Tecnológico 801A, 2º
48160 Derio
Bizkaia - Spain

+34 94 656 7900
info@histocell.com

Histocell Factory

Polígono Sasine. Patakon s/n
48195 Larrabetzu
Bizkaia - Spain

+34 94 656 7900
info@histocell.com

Our mision

We develop new advanced therapy medicinal products, medical devices and dermocosmetics to improve people's quality of life.

Copyright © Histocell